NASDAQ:MLAB - Mesa Laboratories Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$175.00 +7.48 (+4.47 %)
(As of 05/21/2018 04:00 PM ET)
Previous Close$167.52
Today's Range$168.81 - $175.58
52-Week Range$122.35 - $175.58
Volume8,500 shs
Average Volume16,395 shs
Market Capitalization$633.76 million
P/E Ratio41.47
Dividend Yield0.38%
Beta0.51

About Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories logoMesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness. This segment's products are used in healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, environmental air sampling, and semiconductor industries. Its Biological Indicators segment manufactures and markets biological indicators comprising spore strips, self-contained products, and culture media, as well as process challenge devices; and testing services. This segment also distributes chemical indicators that are used to assess the effectiveness of sterilization processes, including steam, hydrogen peroxide, ethylene oxide, and radiation. The company's Cold Chain Monitoring segment offers systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure for use in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and various other laboratory and industrial environments; and parameter monitoring services for products in a cold chain. Its Cold Chain Packaging segment offers packaging development consulting services and thermal packaging products. The company markets its products through distributors in the United States, Europe, Africa, Asia, South America, Australia, Canada, and Central America. Mesa Laboratories, Inc. was founded in 1982 and is headquartered in Lakewood, Colorado.

Receive MLAB News and Ratings via Email

Sign-up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Process control instruments
Sub-IndustryElectronic Equipment & Instruments
SectorMedical
SymbolNASDAQ:MLAB
CUSIP59064R10
Phone303-987-8000

Debt

Debt-to-Equity Ratio0.58
Current Ratio2.37
Quick Ratio1.64

Price-To-Earnings

Trailing P/E Ratio41.47
Forward P/E Ratio30.92
P/E GrowthN/A

Sales & Book Value

Annual Sales$93.67 million
Price / Sales7.06
Cash Flow$7.0451 per share
Price / Cash24.84
Book Value$26.43 per share
Price / Book6.62

Profitability

EPS (Most Recent Fiscal Year)$4.22
Net Income$11.18 million
Net Margins-3.82%
Return on Equity9.20%
Return on Assets5.37%

Miscellaneous

Employees381
Outstanding Shares3,780,000

Mesa Laboratories (NASDAQ:MLAB) Frequently Asked Questions

What is Mesa Laboratories' stock symbol?

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories declared a quarterly dividend on Wednesday, April 4th. Shareholders of record on Thursday, May 31st will be given a dividend of $0.16 per share on Friday, June 15th. This represents a $0.64 annualized dividend and a yield of 0.37%. The ex-dividend date of this dividend is Wednesday, May 30th. View Mesa Laboratories' Dividend History.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) announced its quarterly earnings results on Monday, November, 6th. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.64 by $0.04. The medical instruments supplier earned $22.95 million during the quarter, compared to analyst estimates of $25.50 million. Mesa Laboratories had a negative net margin of 3.82% and a positive return on equity of 9.20%. View Mesa Laboratories' Earnings History.

When is Mesa Laboratories' next earnings date?

Mesa Laboratories is scheduled to release their next quarterly earnings announcement on Tuesday, June, 5th 2018. View Earnings Estimates for Mesa Laboratories.

Who are some of Mesa Laboratories' key competitors?

Who are Mesa Laboratories' key executives?

Mesa Laboratories' management team includes the folowing people:
  • Mr. Gary M. Owens, CEO, Pres & Director (Age 50)
  • Mr. John V. Sakys, Chief Financial & Chief Accounting Officer, Sec. and Treasurer (Age 49)
  • Mr. Glenn E. Adriance, Chief Sales & Marketing Officer (Age 64)
  • Mr. Bryan T. Leo, Sr. VP of Operations
  • Mr. Garrett Krushefski, Sr. VP of Operations

Has Mesa Laboratories been receiving favorable news coverage?

Media coverage about MLAB stock has been trending somewhat positive this week, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Mesa Laboratories earned a media sentiment score of 0.12 on Accern's scale. They also assigned media coverage about the medical instruments supplier an impact score of 46.60 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Who are Mesa Laboratories' major shareholders?

Mesa Laboratories' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (5.01%), Victory Capital Management Inc. (4.47%), Kayne Anderson Rudnick Investment Management LLC (3.35%), Nine Ten Capital Management LLC (2.40%), Thomson Horstmann & Bryant Inc. (2.35%) and King Luther Capital Management Corp (1.18%). Company insiders that own Mesa Laboratories stock include David M Kelly, Glenn E Adriance, H Stuart Campbell, John Bradley Schmieder, John James Sullivan, John Sakys, Michael T Brooks and Robert V Dwyer. View Institutional Ownership Trends for Mesa Laboratories.

Which major investors are selling Mesa Laboratories stock?

MLAB stock was sold by a variety of institutional investors in the last quarter, including King Luther Capital Management Corp, Victory Capital Management Inc., Allianz Asset Management GmbH, Teton Advisors Inc., Nine Ten Capital Management LLC and PNC Financial Services Group Inc.. Company insiders that have sold Mesa Laboratories company stock in the last year include David M Kelly, Glenn E Adriance, H Stuart Campbell, John Bradley Schmieder, John James Sullivan and Robert V Dwyer. View Insider Buying and Selling for Mesa Laboratories.

Which major investors are buying Mesa Laboratories stock?

MLAB stock was bought by a variety of institutional investors in the last quarter, including Kayne Anderson Rudnick Investment Management LLC, BlackRock Inc., Stifel Financial Corp, Comerica Bank, UBS Group AG, Cambridge Investment Research Advisors Inc., Schwab Charles Investment Management Inc. and Royal Bank of Canada. View Insider Buying and Selling for Mesa Laboratories.

How do I buy shares of Mesa Laboratories?

Shares of MLAB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Mesa Laboratories' stock price today?

One share of MLAB stock can currently be purchased for approximately $175.00.

How big of a company is Mesa Laboratories?

Mesa Laboratories has a market capitalization of $633.76 million and generates $93.67 million in revenue each year. The medical instruments supplier earns $11.18 million in net income (profit) each year or $4.22 on an earnings per share basis. Mesa Laboratories employs 381 workers across the globe.

How can I contact Mesa Laboratories?

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier can be reached via phone at 303-987-8000 or via email at [email protected]


MarketBeat Community Rating for Mesa Laboratories (MLAB)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  113 (Vote Outperform)
Underperform Votes:  98 (Vote Underperform)
Total Votes:  211
MarketBeat's community ratings are surveys of what our community members think about Mesa Laboratories and other stocks. Vote "Outperform" if you believe MLAB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MLAB will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Mesa Laboratories (NASDAQ:MLAB) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/ABuy
Consensus Rating Score: N/AN/AN/A3.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Mesa Laboratories (NASDAQ:MLAB) Consensus Price Target History

Price Target History for Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories (NASDAQ:MLAB) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/23/2016Janney Montgomery ScottReiterated RatingBuyN/AView Rating Details
6/10/2016SidotiDowngradeBuy ➝ Neutral$132.00N/AView Rating Details
(Data available from 5/21/2016 forward)

Earnings

Mesa Laboratories (NASDAQ:MLAB) Earnings History and Estimates Chart

Earnings by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories (NASDAQ:MLAB) Earnings Estimates

Current Year EPS Consensus Estimate: $5.66 EPS
Next Year EPS Consensus Estimate: $6.71 EPS

Mesa Laboratories (NASDAQ MLAB) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
6/5/2018$0.84N/AView Earnings Details
2/5/2018Q3 2018$0.53($0.24)$23.10 million$23.67 millionViewN/AView Earnings Details
11/6/2017Q2 2018$0.64$0.60$25.50 million$22.95 millionViewN/AView Earnings Details
7/31/2017Q1 2018$0.56$0.39$22.90 million$22.67 millionViewN/AView Earnings Details
6/7/2017Q4 2017$1.00$1.24$27.10 million$24.30 millionViewN/AView Earnings Details
2/2/2017Q3 2017$0.6150$1.19$22.60 million$23.84 millionViewN/AView Earnings Details
11/2/2016Q217$0.85$0.92$23.80 million$24.40 millionViewN/AView Earnings Details
7/28/2016Q1$0.89$0.89$21.20 million$21.11 millionViewN/AView Earnings Details
6/2/2016Q4$0.94$1.33$21.00 million$24.81 millionViewN/AView Earnings Details
2/2/2016Q3 2016$0.92$19.91 millionViewN/AView Earnings Details
11/2/2015Q2 2016$0.72$21.78 millionViewN/AView Earnings Details
8/3/2015Q116$0.83$0.85$18.78 billion$18.20 billionViewN/AView Earnings Details
6/1/2015Q415$0.91$0.80$18.56 millionViewN/AView Earnings Details
2/2/2015Q315$0.73$0.87$17.83 millionViewN/AView Earnings Details
11/3/2014Q215$0.69$0.84$12.68 million$18.54 millionViewN/AView Earnings Details
8/6/2014Q115$0.67$0.71$11.22 million$16.40 millionViewN/AView Earnings Details
6/2/2014Q414$0.70$1.15$12.80 million$15.70 millionViewN/AView Earnings Details
2/3/2014Q4$0.62$13.12 millionViewN/AView Earnings Details
11/5/2013Q2 2014$0.65$12.68 millionViewN/AView Earnings Details
8/6/2013Q1 2014$0.63$11.22 millionViewN/AView Earnings Details
5/29/2013Q113$0.59$0.76$13.13 million$12.81 millionViewN/AView Earnings Details
2/5/2013Q3 2013$0.67$0.56$11.76 million$11.36 millionViewN/AView Earnings Details
11/8/2012Q312$0.61$0.76$11.48 million$11.71 millionViewN/AView Earnings Details
8/9/2012Q1 2013$0.70ViewN/AView Earnings Details
5/23/2012Q4 2012$0.76ViewN/AView Earnings Details
2/8/2012Q3 2012$0.63ViewN/AView Earnings Details
11/9/2011Q2 2012$0.66ViewN/AView Earnings Details
8/10/2011Q1 2012$0.56ViewN/AView Earnings Details
6/8/2011Q4 2011$0.71ViewN/AView Earnings Details
2/14/2011Q3 2011$0.43ViewN/AView Earnings Details
11/10/2010Q2 2011$0.48ViewN/AView Earnings Details
8/16/2010Q1 2011$0.44ViewN/AView Earnings Details
5/25/2010Q4 2010$0.40ViewN/AView Earnings Details
2/11/2010Q3 2010$0.35ViewN/AView Earnings Details
11/12/2009Q2 2010$0.38ViewN/AView Earnings Details
8/11/2009Q1 2010$0.31ViewN/AView Earnings Details
5/26/2009Q4 2009$0.37ViewN/AView Earnings Details
2/10/2009Q3 2009$0.38ViewN/AView Earnings Details
11/10/2008Q2 2009$0.42ViewN/AView Earnings Details
8/12/2008Q1 2009$0.31ViewN/AView Earnings Details
5/19/2008Q4 2008$0.36ViewN/AView Earnings Details
2/11/2008Q3 2008$0.34ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Mesa Laboratories (NASDAQ:MLAB) Dividend Information

Mesa Laboratories pays an annual dividend of $0.64 per share, with a dividend yield of 0.37%. MLAB's next quarterly dividend payment will be made on Friday, June 15. Mesa Laboratories pays out 15.17% of its earnings out as a dividend.
Next Dividend:6/15/2018
Annual Dividend:$0.64
Dividend Yield:0.37%
Dividend Growth:1.60% (3 Year Average)
Payout Ratio(s):15.17% (Trailing 12 Months of Earnings)
11.31% (Based on This Year's Estimates)
9.54% (Based on Next Year's Estimates)
9.08% (Based on Cash Flow)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories (NASDAQ:MLAB) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/4/2018Quarterly$0.160.42%5/30/20185/31/20186/15/2018
1/2/2018Quarterly$0.160.51%2/27/20182/28/20183/15/2018
10/3/2017quarterly$0.160.42%11/29/201711/30/201712/15/2017
7/6/2017quarterly$0.160.45%8/29/20178/31/20179/15/2017
4/6/2017quarterly$0.160.5%5/26/20175/31/20176/15/2017
1/4/2017quarterly$0.160.51%2/24/20172/28/20173/15/2017
10/5/2016quarterly$0.160.54%11/28/201611/30/201612/15/2016
7/7/2016quarterly$0.160.52%8/29/20168/31/20169/15/2016
4/13/2016quarterly$0.160.64%5/26/20165/31/20166/15/2016
1/6/2016quarterly$0.160.71%2/25/20162/29/20163/15/2016
10/5/2015quarterly$0.160.57%11/25/201511/30/201512/15/2015
7/9/2015quarterly$0.160.72%8/27/20158/31/20159/15/2015
4/3/2015quarterly$0.160.93%5/27/20155/29/20156/15/2015
1/7/2015quarterly$0.160.84%2/25/20152/27/20153/16/2015
10/14/2014quarterly$0.160.95%11/25/201411/28/201412/15/2014
7/17/2014quarterly$0.150.73%8/27/20148/29/20149/15/2014
4/23/2014quarterly$0.150.69%5/28/20145/30/20146/16/2014
1/31/2014quarterly$0.150.75%2/26/20142/28/20143/17/2014
11/1/2013quarterly$0.150.88%11/26/201311/29/201312/16/2013
8/7/2013quarterly$0.140.92%8/28/20138/30/20139/18/2013
4/18/2013quarterly$0.141.1%5/22/20135/27/20136/24/2013
4/17/2013quarterly$0.145/27/20136/14/2013
2/6/2013quarterly$0.141.08%2/25/20132/27/20133/15/2013
(Data available from 1/1/2013 forward)

Insider Trades

Mesa Laboratories (NASDAQ MLAB) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 15.70%
Institutional Ownership Percentage: 73.98%
Insider Trading History for Mesa Laboratories (NASDAQ:MLAB)
Institutional Ownership by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories (NASDAQ MLAB) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/14/2018Robert V DwyerDirectorSell5,000$144.01$720,050.0068,521View SEC Filing  
2/16/2018John James SullivanDirectorSell4,000$138.00$552,000.0072,248View SEC Filing  
2/8/2018John Bradley SchmiederDirectorSell3,000$132.27$396,810.0077,869View SEC Filing  
8/21/2017H Stuart CampbellDirectorSell1,000$130.16$130,160.0042,366View SEC Filing  
8/18/2017H Stuart CampbellDirectorSell2,000$130.42$260,840.0044,366View SEC Filing  
8/15/2017H Stuart CampbellDirectorSell2$134.10$268.2045,366View SEC Filing  
8/11/2017H Stuart CampbellDirectorSell608$134.08$81,520.6445,368View SEC Filing  
8/10/2017H Stuart CampbellDirectorSell1,000$136.58$136,580.0045,976View SEC Filing  
8/9/2017H Stuart CampbellDirectorSell1,000$137.61$137,610.0046,976View SEC Filing  
8/4/2017H Stuart CampbellDirectorSell1,000$143.09$143,090.0047,976View SEC Filing  
8/3/2017H Stuart CampbellDirectorSell2,000$143.37$286,740.0049,976View SEC Filing  
6/16/2017Robert V DwyerDirectorSell11,150$139.46$1,554,979.0080,671View SEC Filing  
6/12/2017David M KellyDirectorSell1,000$142.00$142,000.004,750View SEC Filing  
6/9/2017Glenn E AdrianceInsiderSell4,000$148.98$595,920.0010,000View SEC Filing  
3/20/2017Michael T BrooksDirectorSell2,000$122.94$245,880.0028,900View SEC Filing  
2/22/2017Robert V DwyerDirectorSell5,000$125.13$625,650.0087,971View SEC Filing  
2/21/2017John James SullivanInsiderSell9,078$124.83$1,133,206.7464,278View SEC Filing  
2/13/2017John James SullivanCEOSell5,922$123.99$734,268.7868,040View SEC Filing  
2/7/2017Glenn E AdrianceInsiderSell8,070$124.15$1,001,890.5015,170View SEC Filing  
2/7/2017H Stuart CampbellDirectorSell8,000$121.55$972,400.0055,930View SEC Filing  
11/23/2016Glenn E AdrianceInsiderSell3,567$135.93$484,862.3115,525View SEC Filing  
11/17/2016John SakysCFOSell1,000$127.14$127,140.002,000View SEC Filing  
10/21/2016H Stuart CampbellDirectorSell4,000$119.02$476,080.0063,930View SEC Filing  
9/16/2016H Stuart CampbellDirectorSell3,000$115.03$345,090.0067,930View SEC Filing  
6/22/2016John James SullivanCEOSell4,000$121.63$486,520.0066,118View SEC Filing  
6/6/2016Glenn E AdrianceInsiderSell3,000$111.74$335,220.0014,100View SEC Filing  
3/11/2016H Stuart CampbellDirectorSell6,000$86.32$517,920.0073,887View SEC Filing  
3/7/2016H Stuart CampbellDirectorSell280$90.00$25,200.0076,071View SEC Filing  
2/24/2016H Stuart CampbellDirectorSell1,532$92.90$142,322.8079,766View SEC Filing  
11/6/2015John James SullivanCEOSell2,400$112.99$271,176.0061,393View SEC Filing  
9/22/2015H Stuart CampbellDirectorBuy150$109.54$16,431.0078,848View SEC Filing  
9/17/2015Robert V DwyerDirectorSell2,000$113.00$226,000.0092,373View SEC Filing  
9/15/2015Robert V DwyerDirectorSell3,000$111.67$335,010.0094,373View SEC Filing  
9/11/2015Robert V DwyerDirectorSell1,000$110.00$110,000.0097,373View SEC Filing  
9/8/2015Robert V DwyerDirectorSell1,000$110.39$110,390.0098,373View SEC Filing  
8/17/2015Robert V DwyerDirectorSell1,937$116.50$225,660.50View SEC Filing  
3/14/2014Luke R SchmiederDirectorSell5,000$90.04$450,200.00View SEC Filing  
2/27/2014Glenn E AdrianceInsiderSell1,000$87.68$87,680.00View SEC Filing  
2/25/2014John James SullivanCEOSell10,000$87.01$870,100.00View SEC Filing  
12/9/2013Glenn E AdrianceInsiderSell4,825$73.68$355,506.00View SEC Filing  
11/15/2013Robert V DwyerDirectorSell13,476$71.33$961,243.08View SEC Filing  
11/14/2013Robert V DwyerDirectorSell6,524$71.33$465,356.92View SEC Filing  
8/19/2013John James SullivanCEOSell6,000$64.87$389,220.00View SEC Filing  
8/14/2013John James SullivanCEOSell6,000$61.92$371,520.00View SEC Filing  
3/5/2013H Stuart CampbellDirectorSell30,000$52.75$1,582,500.00View SEC Filing  
12/27/2012Steven W PetersonCFOSell17,054$48.50$827,119.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Mesa Laboratories (NASDAQ MLAB) News Headlines

Source:
DateHeadline
Comparing Mesa Laboratories (MLAB) & Orbotech (ORBK)Comparing Mesa Laboratories (MLAB) & Orbotech (ORBK)
www.americanbankingnews.com - May 21 at 5:33 AM
Esterline (ESL) & Mesa Laboratories (MLAB) Critical ReviewEsterline (ESL) & Mesa Laboratories (MLAB) Critical Review
www.americanbankingnews.com - May 19 at 5:15 PM
Mesa Laboratories (MLAB) vs. Orbotech (ORBK) Head-To-Head AnalysisMesa Laboratories (MLAB) vs. Orbotech (ORBK) Head-To-Head Analysis
www.americanbankingnews.com - May 15 at 3:26 PM
BidaskClub Lowers Mesa Laboratories (MLAB) to BuyBidaskClub Lowers Mesa Laboratories (MLAB) to Buy
www.americanbankingnews.com - May 15 at 12:36 AM
Head-To-Head Analysis: Mesa Laboratories (MLAB) and Fortive (FTV)Head-To-Head Analysis: Mesa Laboratories (MLAB) and Fortive (FTV)
www.americanbankingnews.com - May 13 at 11:16 PM
Zacks: Mesa Laboratories, Inc. (MLAB) Given $175.00 Average Target Price by BrokeragesZacks: Mesa Laboratories, Inc. (MLAB) Given $175.00 Average Target Price by Brokerages
www.americanbankingnews.com - May 13 at 5:35 AM
Mesa Laboratories (MLAB) versus Esterline (ESL) Head-To-Head SurveyMesa Laboratories (MLAB) versus Esterline (ESL) Head-To-Head Survey
www.americanbankingnews.com - May 8 at 9:10 PM
Brokerages Anticipate Mesa Laboratories, Inc. (MLAB) to Announce $2.06 EPSBrokerages Anticipate Mesa Laboratories, Inc. (MLAB) to Announce $2.06 EPS
www.americanbankingnews.com - April 28 at 7:12 PM
Head-To-Head Comparison: Mesa Laboratories (MLAB) & Orbotech (ORBK)Head-To-Head Comparison: Mesa Laboratories (MLAB) & Orbotech (ORBK)
www.americanbankingnews.com - April 26 at 7:20 PM
Mesa Laboratories (MLAB) & Fortive (FTV) Head to Head ComparisonMesa Laboratories (MLAB) & Fortive (FTV) Head to Head Comparison
www.americanbankingnews.com - April 17 at 1:35 AM
Mesa Laboratories (MLAB) Cut to "Sell" at BidaskClubMesa Laboratories (MLAB) Cut to "Sell" at BidaskClub
www.americanbankingnews.com - April 14 at 10:19 PM
TheStreet Lowers Mesa Laboratories (MLAB) to C+TheStreet Lowers Mesa Laboratories (MLAB) to C+
www.americanbankingnews.com - April 14 at 11:13 AM
Zacks: Mesa Laboratories, Inc. (MLAB) Given Average Recommendation of "Strong Buy" by BrokeragesZacks: Mesa Laboratories, Inc. (MLAB) Given Average Recommendation of "Strong Buy" by Brokerages
www.americanbankingnews.com - April 13 at 1:49 PM
Mesa Laboratories (MLAB) Rating Lowered to Strong Sell at Zacks Investment ResearchMesa Laboratories (MLAB) Rating Lowered to Strong Sell at Zacks Investment Research
www.americanbankingnews.com - April 13 at 1:04 PM
Sensata Technologies (ST) & Mesa Laboratories (MLAB) Critical ReviewSensata Technologies (ST) & Mesa Laboratories (MLAB) Critical Review
www.americanbankingnews.com - April 11 at 5:33 AM
Mesa Laboratories (MLAB) Upgraded to Buy at Zacks Investment ResearchMesa Laboratories (MLAB) Upgraded to Buy at Zacks Investment Research
www.americanbankingnews.com - April 8 at 10:23 AM
Mesa Laboratories (MLAB) Lifted to "Strong-Buy" at BidaskClubMesa Laboratories (MLAB) Lifted to "Strong-Buy" at BidaskClub
www.americanbankingnews.com - April 7 at 9:29 AM
ValuEngine Upgrades Mesa Laboratories (MLAB) to "Buy"ValuEngine Upgrades Mesa Laboratories (MLAB) to "Buy"
www.americanbankingnews.com - April 3 at 12:10 PM
Mesa Laboratories (MLAB) Rating Increased to B at TheStreetMesa Laboratories (MLAB) Rating Increased to B at TheStreet
www.americanbankingnews.com - April 1 at 11:23 AM
Mesa Laboratories (MLAB) Stock Rating Lowered by Zacks Investment ResearchMesa Laboratories (MLAB) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - March 31 at 4:56 PM
Mesa Laboratories (MLAB) Upgraded at Zacks Investment ResearchMesa Laboratories (MLAB) Upgraded at Zacks Investment Research
www.americanbankingnews.com - March 30 at 9:17 AM
 Mesa Laboratories, Inc. (MLAB) Given $175.00 Average Target Price by Brokerages Mesa Laboratories, Inc. (MLAB) Given $175.00 Average Target Price by Brokerages
www.americanbankingnews.com - March 29 at 10:15 AM
BidaskClub Lowers Mesa Laboratories (MLAB) to SellBidaskClub Lowers Mesa Laboratories (MLAB) to Sell
www.americanbankingnews.com - March 26 at 1:58 PM
Mesa Laboratories (MLAB) Rating Lowered to Sell at Zacks Investment ResearchMesa Laboratories (MLAB) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - March 26 at 12:45 PM
Mesa Laboratories (MLAB) Upgraded at BidaskClubMesa Laboratories (MLAB) Upgraded at BidaskClub
www.americanbankingnews.com - March 25 at 10:29 AM
Mesa Laboratories (MLAB) Lifted to "Hold" at Zacks Investment ResearchMesa Laboratories (MLAB) Lifted to "Hold" at Zacks Investment Research
www.americanbankingnews.com - March 24 at 6:46 PM
 Mesa Laboratories, Inc. (MLAB) Receives Consensus Recommendation of "Strong Buy" from Brokerages Mesa Laboratories, Inc. (MLAB) Receives Consensus Recommendation of "Strong Buy" from Brokerages
www.americanbankingnews.com - March 23 at 3:34 PM
Insider Selling: Mesa Laboratories, Inc. (MLAB) Director Sells 5,000 Shares of StockInsider Selling: Mesa Laboratories, Inc. (MLAB) Director Sells 5,000 Shares of Stock
www.americanbankingnews.com - March 19 at 10:18 AM
 Mesa Laboratories, Inc. (MLAB) Given $175.00 Consensus Target Price by Brokerages Mesa Laboratories, Inc. (MLAB) Given $175.00 Consensus Target Price by Brokerages
www.americanbankingnews.com - March 18 at 9:28 AM
Mesa Laboratories (MLAB) Upgraded by BidaskClub to "Buy"Mesa Laboratories (MLAB) Upgraded by BidaskClub to "Buy"
www.americanbankingnews.com - March 17 at 5:34 PM
Mesa Laboratories, Inc. (MLAB) Position Lifted by Ranger Investment Management L.P.Mesa Laboratories, Inc. (MLAB) Position Lifted by Ranger Investment Management L.P.
www.americanbankingnews.com - March 6 at 2:11 PM
Brokerages Expect Mesa Laboratories, Inc. (MLAB) to Announce $0.76 EPSBrokerages Expect Mesa Laboratories, Inc. (MLAB) to Announce $0.76 EPS
www.americanbankingnews.com - March 3 at 3:36 AM
Mesa Laboratories, Inc. (MLAB) Shares Bought by King Luther Capital Management CorpMesa Laboratories, Inc. (MLAB) Shares Bought by King Luther Capital Management Corp
www.americanbankingnews.com - February 28 at 1:19 PM
Royce & Associates LP Has $9.79 Million Position in Mesa Laboratories, Inc. (MLAB)Royce & Associates LP Has $9.79 Million Position in Mesa Laboratories, Inc. (MLAB)
www.americanbankingnews.com - February 26 at 12:20 PM
Investors In Mesa Laboratories Inc (NASDAQ:MLAB) Are Paying Above The Intrinsic ValueInvestors In Mesa Laboratories Inc (NASDAQ:MLAB) Are Paying Above The Intrinsic Value
finance.yahoo.com - February 23 at 5:34 PM
John James Sullivan Sells 4,000 Shares of Mesa Laboratories, Inc. (MLAB) StockJohn James Sullivan Sells 4,000 Shares of Mesa Laboratories, Inc. (MLAB) Stock
www.americanbankingnews.com - February 20 at 12:16 PM
 Mesa Laboratories, Inc. (MLAB) Given Average Rating of "Strong Buy" by Analysts Mesa Laboratories, Inc. (MLAB) Given Average Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - February 15 at 1:28 AM
Mesa Laboratories (MLAB) Lowered to "C" at TheStreetMesa Laboratories (MLAB) Lowered to "C" at TheStreet
www.americanbankingnews.com - February 10 at 1:56 PM
Mesa Laboratories (MLAB) Downgraded by Zacks Investment Research to SellMesa Laboratories (MLAB) Downgraded by Zacks Investment Research to Sell
www.americanbankingnews.com - February 10 at 6:28 AM
Insider Selling: Mesa Laboratories, Inc. (MLAB) Director Sells 3,000 Shares of StockInsider Selling: Mesa Laboratories, Inc. (MLAB) Director Sells 3,000 Shares of Stock
www.americanbankingnews.com - February 8 at 6:16 PM
CBMG Up 50% YTD, HAIR Keeps Falling, MNOV To Report NASH Trial Data In AprilCBMG Up 50% YTD, HAIR Keeps Falling, MNOV To Report NASH Trial Data In April
www.nasdaq.com - February 8 at 8:27 AM
Mesa Labs reports 3Q lossMesa Labs reports 3Q loss
finance.yahoo.com - February 6 at 9:36 AM
Are Mesa Laboratories Inc’s (NASDAQ:MLAB) Interest Costs Too High?Are Mesa Laboratories Inc’s (NASDAQ:MLAB) Interest Costs Too High?
finance.yahoo.com - January 31 at 10:04 AM
Zacks: Mesa Laboratories, Inc. (MLAB) Receives Consensus Recommendation of "Strong Buy" from BrokeragesZacks: Mesa Laboratories, Inc. (MLAB) Receives Consensus Recommendation of "Strong Buy" from Brokerages
www.americanbankingnews.com - January 31 at 5:16 AM
Mesa Laboratories (MLAB) Set to Announce Quarterly Earnings on WednesdayMesa Laboratories (MLAB) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - January 24 at 3:56 AM
 Mesa Laboratories, Inc. (MLAB) Given Average Recommendation of "Strong Buy" by Analysts Mesa Laboratories, Inc. (MLAB) Given Average Recommendation of "Strong Buy" by Analysts
www.americanbankingnews.com - January 16 at 9:56 AM
Rudolph Technologies (RTEC) versus Mesa Laboratories (MLAB) Head to Head ContrastRudolph Technologies (RTEC) versus Mesa Laboratories (MLAB) Head to Head Contrast
www.americanbankingnews.com - January 11 at 3:34 PM
Mesa Laboratories, Inc. to Issue Quarterly Dividend of $0.16 (MLAB)Mesa Laboratories, Inc. to Issue Quarterly Dividend of $0.16 (MLAB)
www.americanbankingnews.com - January 3 at 12:36 PM
Mesa Labs Declares Quarterly DividendMesa Labs Declares Quarterly Dividend
finance.yahoo.com - January 2 at 6:58 PM
Zacks: Analysts Set $175.00 Price Target for Mesa Laboratories, Inc. (MLAB)Zacks: Analysts Set $175.00 Price Target for Mesa Laboratories, Inc. (MLAB)
www.americanbankingnews.com - January 1 at 1:56 AM

SEC Filings

Mesa Laboratories (NASDAQ:MLAB) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Mesa Laboratories (NASDAQ:MLAB) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Mesa Laboratories (NASDAQ MLAB) Stock Chart for Monday, May, 21, 2018

Loading chart…

This page was last updated on 5/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.